| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.74▼ | 4.75▼ | 4.75▼ | 4.65▲ | 4.40▲ |
| MA10 | 4.74▼ | 4.76▼ | 4.79▼ | 4.53▲ | 4.30▲ |
| MA20 | 4.75▼ | 4.81▼ | 4.76▼ | 4.42▲ | 3.80▲ |
| MA50 | 4.76▼ | 4.71▲ | 4.56▲ | 4.30▲ | 3.53▲ |
| MA100 | 4.80▼ | 4.55▲ | 4.49▲ | 3.81▲ | 3.36▲ |
| MA200 | 4.78▼ | 4.46▲ | 4.42▲ | 3.57▲ | 2.93▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.020▼ | -0.021▼ | 0.029▲ | 0.087▲ |
| RSI | 36.342▼ | 44.239▼ | 52.177▲ | 60.673▲ | 68.798▲ |
| STOCH | 37.222 | 12.522▼ | 18.314▼ | 68.458 | 59.565 |
| WILL %R | -100.000▼ | -100.000▼ | -57.143 | -25.444 | -19.946▲ |
| CCI | -131.404▼ | -99.204 | -104.535▼ | 168.545▲ | 93.892 |
|
Tuesday, October 07, 2025 03:46 PM
Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, October 07, 2025 01:00 AM
Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...
|
|
Thursday, November 07, 2024 04:00 PM
* Each market will close early at 1:00 p.m. (1:15 p.m. for eligible options) on Thursday, July 3, 2025. Crossing Session orders will be accepted beginning at 1:00 p.m. for continuous executions until ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 4.85 | 4.905 | 4.71 | 4.73 | 808,757 |
| 30/10/25 | 4.58 | 4.945 | 4.54 | 4.84 | 1,842,062 |
| 29/10/25 | 4.59 | 4.76 | 4.51 | 4.61 | 1,183,471 |
| 28/10/25 | 4.47 | 4.605 | 4.40 | 4.58 | 689,169 |
| 27/10/25 | 4.36 | 4.48 | 4.30 | 4.47 | 929,914 |
| 24/10/25 | 4.30 | 4.435 | 4.26 | 4.36 | 786,875 |
| 23/10/25 | 4.42 | 4.435 | 4.27 | 4.28 | 709,475 |
| 22/10/25 | 4.48 | 4.51 | 4.375 | 4.43 | 693,798 |
| 21/10/25 | 4.54 | 4.61 | 4.45 | 4.48 | 607,231 |
| 20/10/25 | 4.41 | 4.595 | 4.28 | 4.55 | 838,669 |
|
|
||||
|
|
||||
|
|